PCVX
Vaxcyte Inc
$88.39
Earnings Summary
Net Profits | $-103.12Mn |
Highlights
Net Profits:
Vaxcyte Inc’s net profit fell -11.29% since last year same period to $-103.12Mn in the Q3 2024. On a quarterly growth basis, Vaxcyte Inc has generated 19.87% jump in its net profits since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Vaxcyte Inc post its latest quarter earnings
EPS Estimate Current Quarter | -1.13 |
EPS Estimate Current Year | -1.13 |
Highlights
EPS Estimate Current Quarter:
Vaxcyte Inc’s earning per share (EPS) estimates for the current quarter stand at -1.13 - a -15.31% fall from last quarter’s estimates.
EPS Estimate Current Year:
Vaxcyte Inc’s earning per share (EPS) estimates for the current year stand at -1.13.
Key Ratios
Key ratios of the Vaxcyte Inc post its Q3 2024 earnings
Earning Per Share (EPS) | -0.83 |
Highlights
Earning Per Share (EPS):
Vaxcyte Inc’s earning per share (EPS) jumped 8.79% since last year same period to -0.83 in the Q3 2024. This indicates that the Vaxcyte Inc has generated 8.79% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-08-06 | -0.98 | -1.1 | -12.24% |
2024-05-08 | -1.17 | -0.85 | 27.35% |
2024-11-05 | -1.13 | -0.83 | 26.55% |
₹0 US Stocks a/c Opening Fee